Please login to the form below
Sagent appoints Michael Fekete to board
Will support growth of injectables firm following initial public offering
Sagent Pharmaceuticals has appointed Michael Fekete as the sixth member of its board of directors.
Fekete is currently director at both pharma firm DFB Pharmaceuticals and Symetis SA, which creates minimally invasive heart valve replacement therapies for patients suffering from heart valve diseases.
He is a corporate adviser specialising in capital markets, mergers and acquisitions and general corporate strategy and has experience at Oppenheimer & Co and L F Rothschild & Co.
Illinois, US-based injectable specialist Sagent will benefit from his advice as it looks to expand following its successful initial public offering, which Fekete assisted in an advisory role.
“Mike's experience and skill set will be particularly valuable to us as we continue to drive our growth,” said Jeffrey Yordon, founder, CEO and chairman of the board of Sagent.
“We look forward to his contribution to the board of directors and his involvement with senior management of the company."
Featured jobs
-
Account Manager (PR)
-
Great Benefits
-
Account director
-
Competitive salary and bonus scheme
-
Experienced medical editor
-
Competitive salary and bonus scheme
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
-
Account Director, Medical Education
-
Salary TBC
- Account Director, Healthcare Communications
-
Salary TBC
-
Publications director
-
Competitive salary and bonus scheme
- Client Services Director - Digital MedComms
-
£60000 - £80000 per annum, Benefits: Pension, healthcare, dedicated training budget, regul
-
Account Director
-
£Competitive Salary
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Account Manager
-
£Competitive Salary
-
Senior External Communications Lead
-
£Competitive Salary
- Digital Associate Director - Medcomms
-
£65000 - £80000 per annum
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Scientific Director
-
£60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
Subscribe to our email news alerts
- Seattle Genetics wins FDA priority review for oral HER2 drug
- Merck chases Roche with triple-negative breast cancer data for Keytruda
- BMS unveils long-term results for Opdivo in kidney cancer
- Merck chases Roche with triple-negative breast cancer data for Keytruda
- J&J gets US backing for vaccine against coronavirus, christened Covid-19
- Novartis plans inclisiran trial in the UK
- Ex-Sandoz exec admits role in generic drug price-fixing plot
- Spotlight interview: 15 minutes on Independent Medical Education
- Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD
- Merck’s Ebola vaccine wins approval in four African countries
- ReNeuron set for recovery after Woodford stake sale
- Servier and Oncodesign reach first milestone in Parkinson’s partnership
PMHub
Six Degrees Medical Consulting
For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...
Latest intelligence
- Enabling market access through outcomes-based pricing
- Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
- 20 for 2020 – Five pharma companies to watch
- As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
- The growing clinical importance of patient-reported outcomes (PROs)
- Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
Quick links
Infographics
